The research highlights of 2019 include: approval of a PARP inhibitor, artificial intelligence to diagnose pancreatic cysts, and updated radiation guidelines.
Researchers are using blood samples to follow people considered at-risk for developing pancreatic cancer in a trial looking for early detection biomarkers.
Do you want to better understand your pancreatic cancer treatment? Dr. Andrew Hendifer outlines important questions to ask before starting chemotherapy.